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a  b  s  t  r  a  c  t
For  3-dimensional  (3D)  imaging  of  a tissue,  3 methodological  steps  are  essential  and  their
successful  application  depends  on speciﬁc  characteristics  of  the type  of  tissue.  The  steps
are 1◦ clearing  of  the  opaque  tissue  to render  it transparent  for microscopy,  2◦ ﬂuorescence
labeling  of the  tissues  and  3◦ 3D imaging.  In the past  decades,  new  methodologies  were
introduced  for  the clearing  steps  with  their speciﬁc  advantages  and  disadvantages.  Most
clearing  techniques  have  been  applied  to the central  nervous  system  and  other  organs
that contain  relatively  low  amounts  of  connective  tissue  including  extracellular  matrix.
However,  tissues  that  contain  large  amounts  of  extracellular  matrix  such as  dermis  in skin
or gingiva  are  difﬁcult  to  clear.  The  present  survey  lists  methodologies  that are  available  for
clearing  of tissues  for 3D imaging.  We  report  here  that  the  BABB  method  using  a mixture
of  benzyl  alcohol  and  benzyl  benzoate  and iDISCO  using  dibenzylether  (DBE)  are  the  most
successful  methods  for  clearing  connective  tissue-rich  gingiva  and  dermis  of  skin  for 3D
histochemistry  and  imaging  of  ﬂuorescence  using  light-sheet  microscopy.
©  2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the
CC BY  license  (http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
Anatomical investigations of the human body through surgery and autopsy are the oldest ways to diagnose diseases and to
observe effects of therapy. These macroscopical anatomical analyses were already performed in ancient cultures such as those
of the Egyptians, Chinese, Persians and Greek. Today, it is still a major approach to deal with diseases such as cancer. However,
complementary to macroscopical investigations, microscopical exploration of anatomical structures through histology has
been developed in the past centuries since the microscope was  invented by Van Leeuwenhoek. Histology has opened a new
avenue to understand structure and morphology of tissues and their pathological changes down to the molecular level. It
tremendously improved the quality of diagnosis and the monitoring of the effects of therapy in such a way that nowadays
histological evaluation is absolutely indispensable. However, traditional 2D histological assessment of tissues limits proper
insights in 3D tissue structure. For example, to explore the connectivity of local cellular networks, 3D imaging is essential
(Denk and Horstmann, 2004). Imaging of serial sections of a tissue and subsequent 3D reconstruction of the tissue on the
basis of those images have been developed successfully (Fig. 1, Grifﬁni et al., 1997), but its application remained limited to
small volumes of tissue (Chieco et al., 2013; Chung et al., 2013; Grifﬁni et al., 1997) and it is a time-consuming and error-
prone procedure. 3D imaging of tissues is hampered by the fact that tissues are opaque and thus do not allow light to pass
what is essential for microscopy. Alternatively, optically-transparent organisms can be used such as embryos of zebraﬁsh
(Vittori et al., 2015; Wenner, 2009). However, mammalian tissues including human tissues are not transparent except for the
cornea, vitreous, lens and retina in the eye (de Carvalho et al., 2014). Optical tissue clearing (OTC) has been developed to study
opaque tissues. As we describe in this review, OTC is performed by immersion of tissues in optical clearing agents to reduce
scattering and makes tissues transparent. Tissues are packed with components of different refractive indices (RIs), including
scattering particles with high RI such as collagen, elastic ﬁbers, cells, cell membranes and organelles and surrounding media
with lower RI i.e. interstitial ﬂuid or cytosol. This architecture forces light to travel at different speeds and angles because
each component has different refractive properties (Dodt et al., 2007; Zhu et al., 2010).
Imaging in 3D of tissues has become feasible because of developments in microscopy in the last decades, such as (2-
photon) confocal laser scanning microscopy and light sheet microscopy, but the opaqueness of most tissues prevents proper
imaging. One of the approaches to facilitate 3D microcopy of tissues is clearing of the tissue.Recent years have witnessed a burst of high-impact papers in the ﬁeld of 3D tissue imaging that describe in particular
novel methods to clear tissues. In the present review, we  discuss which clearing methods are optimal for which conditions.
Fig. 1. 3D reconstruction of experimental metastasis of rat colon carcinoma cells in rat liver on the basis of images of 2D serial sections of liver containing
the  tumors (Grifﬁni et al., 1997). (a) Metastasis of cancer cells (blue) completely encapsulated by connective tissue (pink) with surrounding portal tracts
(green). (b) Metastasis showing invasive growth of cancer cells (blue) through surrounding connective tissue (pink). Yellow: lever capsule; green: portal
tracts;  Bar = 3 mm.  Note the artefacts in the reconstruction due to imperfect alignment of the images of serial sections which is particularly evident in the
surface of the lever and the portal tracts.
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.1. Clearing methodologies in historical perspective
The German anatomist Werner Spalteholz (1861–1940) (Spalteholz, 1911, 1914) was the ﬁrst scientist who  investi-
ated clearing of tissues. He was studying anastomoses between coronary arteries in the heart and could not make any
reakthrough discoveries with standard research methods. Until then (1906), tissues were examined by using preparation
echniques for macroscopical and microscopical inspection or by using X-ray diagnostics. Spalteholz realized that for making
ew discoveries new methods would be necessary and started to investigate alternative methods. Through previous research
n muscle tissue, he knew that muscle tissue becomes transparent when dehydrated with the use of alcohol followed by
love oil or xylene and then stored in Canada balsam. He found out that transparency of tissue was highest when light is
ot reﬂected on the surface of the tissue, which is the case when the RI of the tissue is the same as the RI of the medium
r the solution that holds the tissue. Spalteholz investigated the RI of tissues and found that different tissues have different
Is that also vary with age. He tested different media to match tissue RIs. For example, when benzene was  used instead of
ylene the RI appeared to be decreased, whereas the RI of carbon disulﬁde was  higher and thus he started to mix  solutions.
t appeared that when the RI was too high, tissue was  not transparent and when the RI was  too low, refraction and reﬂec-
ion of light at the surface of the tissue interfered with microscopic visualization. Spalteholz reported a clearing solution
hat had the ideal chemical characteristics for clearing, namely methyl salicylate and benzyl benzoate (BB) in combination
ith wintergreen oil. His clearing method was published in 1911 and consisted of the steps that are listed here including
odiﬁcations introduced since 1911:
. Preparation of the tissue.
. Fixation of the tissue using formalin (or better freshly-prepared paraformaldehyde).
. Decalciﬁcation of bone, when present in the tissue samples.
. Bleaching of the tissue to prevent absorption of light by endogenous pigments. The most simple bleaching procedure
is based on the use of hydrogen peroxide to oxidize pigment. The incubation time depends on the consistency of the
tissue and the size of the tissue sample. When bleaching with hydrogen peroxide only is not successful due to the tissue
consistency, bleaching ﬁrst using hydrogen peroxide and subsequent ﬁxation using 10% paraformaldehyde may  be helpful.
. Rinsing of tissue using tap water to remove all hydrophilic chemical compounds.
. Dehydration in an ascending series of alcohol. The ﬁnal clearing solution is hydrophobic and cannot be mixed with water,
thus dehydration is necessary.
. Incubation in benzene as 100% alcohol can be mixed with benzene. A transfer directly from alcohol to the ﬁnal clearing
solution is possible but alcohol can reduce the transparency of tissue. Therefore, the intermediate step of incubation in
benzene improves clearing. Benzene can be removed by using a vacuum pump.
. Incubation in the clearing solution containing methyl salicylate, BB and wintergreen oil.
Disadvantages of this method were tissue shrinkage due to wintergreen oil and the formation of bubbles due to effects
f hydrogen peroxide (Cumley et al., 1939). Necrosis occurred in the outer layers of the tissue (Steinke and Wolff, 2001),
hich made histological examination difﬁcult.
In the same period of time, Lundvall started similar experiments to clear embryos. He used a mixture of 1 part carbon
isulﬁde and 4 parts benzene, but his results were only satisfying when clearing embryos. The largest drawback of the use
f carbon disulﬁde was, besides its toxicity, the smell that is hard to handle for longer periods of time. Furthermore, he
uccessfully introduced oxalic acid for the bleaching step instead of hydrogen peroxide, which appeared to be more pure
ut was also more expensive at that time. BB has been frequently used, for example by Orsini in 1962 to show details of
eproductive tracts (Orsini, 1962). Her clearing method was  based on that of Lundvall, who  dehydrated tissues in ascending
lcohol series, bleached with hydrogen peroxide and cleared the tissue in BB. However, BB only appeared to be insufﬁcient
o achieve complete transparency of tissues, so the method had to be modiﬁed further.
Another development of the Spalteholz clearing method was published in 1924 by Ljetnik (1924). He introduced plastics
hat were generated by polymerization of monomers to replace essential oils such as wintergreen oil and to obtain a block
f plastic that contained the tissue.
Eitel et al. (1986) performed macroscopical studies using Spalteholz’ preparation technique, and Piechocki (1986)
eported new ways to embed tissues. The major problem with these methods was  that the treatment of tissues caused
issue damage whereas histological examination was not possible. Peters (1961) demonstrated that a mixture of BB and
imethyl phthalate (DMP) preserved the histology well during the clearing process (Steinke and Wolff, 2001).
von Hagens et al. (1987) developed another method to obtain transparent tissue specimens. His aim was  different, because
he study was performed to preserve specimens for teaching purposes and as a result he developed a method for plastination
f specimens that became famous. It was based on the principle to replace water and lipids in tissues by plastic monomers
hat then can be polymerized to form plastic blocks containing the tissue sample. There are various ways to plastinate tissues,
ut tissue slices with a thickness of approx. 2.5 mm are transparent after polymerization.A combination of the plastination technique of von Hagens et al. (1987) and the clearing technique of Spalteholz (1911)
as been investigated as well. Seibold in 1990 tried to combine the methods but failed and Steinke and Wolff (2001) reported
hat the different RIs of the plastination resin and the clearing solution did not allow clearing of larger specimens. Steinke
nd Wolff (2001) also reported another modiﬁcation of the Spalteholz’ technique. First, erythrocytes were removed by
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rinsing out the blood vessels with a buffer to prevent formation of a brown colour in the tissue samples due to oxidized
hemoglobin when cleared with the Spalteholz technique. Furthermore, tissue samples were not chemically ﬁxed using
formaldehyde but frozen. However, bleaching was still necessary to prevent that pigments absorb light. Steinke and Wolff
bleached with acetone and peracetic acid instead of hydrogen peroxide to minimize structural damage. Then, samples were
cleared according to the method of Peters (1961) using BB and DMP. The results of this modiﬁed Spalteholz technique were
good, especially for histological examination of tissues. Its drawback was  that the procedure was  time consuming and tissue
damage still occurred.
At this point, new developments in microscopy enabled true 3D microscopy of tissues and progress was made rapidly
including the clearing methodology. For the study of blood vessels in tissues, various approaches have been used. Steinke
and Wolff (2001) obtained the best results by injecting a gelatin solution to keep the lumen of blood vessels open after the
gelatin had solidiﬁed.
1.2. Clearing methodologies presently used
At present, 10 approaches to clear tissue are used for imaging. They are described in the following chapter. Characteristics
of the approaches are summarized in Table 1 .
1.3. BABB
In 2007, Dodt et al. reported that a BABB consisting of 1 part benzyl alcohol (BA) and 2 parts BB was an excellent clearing
mixture for mouse brains and embryos and fruit ﬂies (Dodt et al., 2007). This clearing method was applied to clear Xenopus
embryos and oocytes (Dent et al., 1989; Keller and Dodt, 2012).
BB was introduced as clearing solution by Spalteholz in 1911. Becker et al. (2008) improved the BABB clearing protocol by
introducing Dentı´s Fix solution to prepare mouse embryos and fruit ﬂies for clearing. Dentı´s Fix contains 1 part dimethylsul-
foxide (DMSO) and 4 parts methanol. Bleaching was performed using hydrogen peroxide. Jährling et al. (2009) also cleared
mouse brains, spinal cord and hearts using the BABB protocol without using Dent’s Fix, while Oldham et al. (2008) also
cleared other organs of mice like kidney and liver. However, clearing with the use of BABB was reported to reduce ﬂuo-
rescence signals due to quenching (Yushchenko and Schultz, 2013). This aspect of the BABB clearing method is discussed
below. Furthermore, labeling artefacts have been described after BABB clearing (Kuwajima et al., 2013). Furthermore, tissue
shrinkage is a problem for clearing procedures based on the use of BABB (Hama et al., 2011; Ke et al., 2013) but also when
using other clearing methods. Nevertheless, BABB was one of the ﬁrst clearing methods developed, it has been used for many
different tissues and always resulted in satisfying transparency of tissues.
1.4. Scale
Hama et al. (2011) had observed that polyvinylidene ﬂuoride membranes become transparent in an aqueous solution of
urea. This phenomenon inspired the authors to apply urea for clearing of tissues which is an entirely different approach from
existing clearing methodologies because urea can be used in aqueous solutions. The major advantage of performing clearing
in a hydrophilic environment is that after clearing ﬂuorescence signals in transparent tissues are preserved and enables the
application of ﬂuorescently-labeled antibodies against biomarkers (Yushchenko and Schultz, 2013). However, this aspect
is discussed below. It is a simple method that does not need speciﬁc (expensive) equipment. The RI of urea-containing
aqueous solutions is similar to the RI of water, which facilitates imaging with water-immersion objectives. The advantages
are the long working distance and the high numeral aperture (Marx, 2014). One of the most effective clearing solutions he
tested was ScaleA2, which contains 4 M urea, 10% glycerol and 0.1% Triton X-100. The solution is colorless and is transparent
for light with a wavelength >300 nm.  Samples maintain their macroscopic structure and quenching of ﬂuorescence signals
does not occur, but samples turn soft and fragile due to protein loss (Keller and Dodt, 2012; Steinke and Wolff, 2001). To
reduce fragility, Hama et al. (2015) developed the solution ScaleU2, which contains 30% glycerol instead of 10%. Besides a
better stability of the tissues, shrinkage of tissue was  not observed. Lately Hama et al. (2015) developed another improved
method, named ScaleS. The sugar-alcohol sorbitol is combined when using with urea, which results in better preservation
of ﬂuorescence and in better transparency than when using ScaleA2.
Hama et al. (2011) tested Scale only on mouse brain and mouse embryos, but it was  assumed that this technique would
also be effective when applied to other tissues. ScaleS has been used on postmortem human brain from patients who  suffered
from Alzheimerı´s disease (Hama et al., 2015). Becker et al. (2012) critically evaluated clearing using Scale on mouse brain
and muscle preparations. It was concluded that regions in the brain with a high content of myelin and muscle tissue did
not become clear at all. Moreover, a drawback is the long incubation time up to months that is needed to render tissue
transparent (Keller and Dodt, 2012).1.5. 3DISCO
Becker et al. (2012) investigated alternatives for the BABB clearing protocol, because it was  assumed that BABB clearing
does not preserve ﬂuorescence signals. It was found that DBE preserve ﬂuorescence signals better than BABB. DBE has a similar
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Table 1
Overview of clearing methods for 3D imaging of tissues and their practical aspect (tissue types tested, duration of the clearing procedure, staining methods tested, protocol of clearing).
Clearing  method
(non-aqueous  clearing)
BABB  3DISCO  iDISCO
Tissues  types  tested  Mouse  brain  and
embryo,  fruit  ﬂy  (Dodt
et al., 2007);  rat  heart
and lung,  mouse  brain,
tumor  and  kidney
(Oldham  et  al.,  2008)
Mouse  mammary  gland,
lymph node,  spinal  cord,
lung,  spleen,  brain  stem,
brain  and  pancreas
(Ertürk  et al.,  2012a,b,
2014)
Mouse  spinal  cord,  brain,
lung and  pancreas
(Renier  et  al.,  2014)
Number of
steps/duration  of
procedure
32 steps/4  days  10  steps/4  h-4 days  29  steps/4  days
(Immuno) histochemical
staining  tested
Neu-N  FITC  Aquaporin2
Steptavidin-Cy3 CD24  -Catenin
-Smooth muscle  actin  -Galatosidase
Alexa Fluor  488 cFos
Cleaved  caspase  3
Cleaved  caspase  9
E-cadherin
Fox P2
GFP
Laminin
N-Cadherin
Nephrin
Neuroﬁlament-M
Parvalbumin
PeCAM
Phospho-cJun
Phospho-histone-H3
RFP
Ret
Robo3
TrkA
TrkB
TrkC
Tuj
Tyrosine  hydroxylase
Cholera toxin  
EdU
TO-PRO-3
Protocol Fix  in PFA Until  dehydration R.T.  Remove  blood  by
perfusion  with  PFA  or
PBS
Fix  in  PFA Until  dehydration R.T.
Incubate twice  in  PBS Each  1  h Postﬁx  with  PFA Overnight  R.T.  Incubate  twice  in  PBS Each  1 h
Incubate in  50%
methanol  in PBS
1  h  Incubate  in 50%  THF/
50%  PBS
20  min–12  h Incubate  in  50%
methanol  in PBS
1  h
Incubate in  80%
methanol  in PBS
1  h Incubate  in 70%  THF/
30%  PBS
20  min–12  h Incubate  in  80%
methanol  in PBS
1  h
Incubate twice  in  100%
methanol
Each  1  h  Incubate  in 80%  THF/
20%  PBS
20  min–12  h Incubate  twice  in  100%
methanol
Each 1 h
Bleach with  5%  H2O2in
20%  DMSO/methanol
(ice cold)
Over-night  4 ◦C Incubate  in 100%  THF  3×  20  min–12  h  Bleach  with  5%  H2O2in
20%  DMSO/methanol
(ice cold)
Over-night  4 ◦C
Incubate 3  times  in 100%
methanol
Each  1  h  R.T.  Incubate  in DCM  15–45  min  Incubate  3  times  in  100%
methanol
Each 1 h R.T.
Incubate twice  in  20%
DMSO  in methanol
Each  1  h Incubate  in DBE 15  min—1–2  days Incubate  twice  in  20%
DMSO  in methanol
Each  1 h
Incubate in  80%
methanol  in PBS
1  h  Incubate  in  80%
methanol  in PBS
1  h
Incubate in  50%
methanol  in PBS
1  h  Incubate  in  50%
methanol  in PBS
1  h
14
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Table 1 (Continued)
Clearing  method
(non-aqueous  clearing
methods)
BABB  3DISCO  iDISCO
Incubate  twice  in PBS  Each  1  h  Incubate  twice  in PBS  Each  1  h
Incubate in PBS/0.2%
Triton  X-100
1  h Incubate  in PBS/0.2%
Triton  X-100
1  h
Incubate 4 times  in
PBS/0.2%  Tween-20
Each  1  h  Incubate  4  times  in
PBS/0.2%  Tween-20
Each  1  h
Incubate in 50%
methanol/H2O
1  h Incubate  in 50%
THF/H2O
Over-night
Incubate in 70%
methanol/H2O
1  h Incubate  in 80%
THF/H2O
1  h
Incubate in 80%
methanol/H2O
1  h Incubate  twice  in 100%
THF
Each 1  h
Incubate in 96%
methanol/H2O
1  h Incubate  in DCM  Until  sample  sinks
Incubate 3 times  in  100%
methanol
Each  1  h  Incubate  in DBE  Until  sample  is  clear
Incubate in 50%
BABB/50%  methanol
Over-night
Incubate  in BABB  Until  sample  is  clear
Clearing method
(aqueous  clearing)
Scale  ClearT  SeeDB  CUBIC
Tissues  types  tested  Mouse  brain  and  embryo
(Hama  et  al.,  2011)
Mouse  brain  and  embryo
(Kuwajima  et  al.,  2013)
Mouse  brain  (Ke  et  al.,
2013)
Mouse  brain  (Susaki
et al.,  2014)
Number of
steps/duration  of
procedure
2  steps/days-weeks
(Scale  A2),
weeks-months  (Scale
U2)
4–6  steps/day  7  steps/3  days  5–7  steps/15–19  days
(Immuno) histochemical
staining  tested
FluoroMyelinTMred  RC2  Gephyrin  VIP
PSA-NCAM Mouse  monoclonal
Neuroﬁlament
Gephyrin  (synaptic
systems)
Copeptin
Brain lipid-binding
protein
Immunoglobulin  M Microtubule-associated
protein  2
SYTO-16
Alexa Fluor  546  Alexa
Fluor  633
Alexa  647
GLUT1 DAPI
Tyrosine  hydrolase
Protocol Fix  in  PFA  Fix  in  PFA  or  perfuse
with  PBS  at  4 ◦C
Fix  in  PFA  Fix  in  PFA
Incubate in  ScaleA2  or
ScaleU2  until  samples
are clear
Day–month  ClearT Incubate  in  20%  (wt/vol)
fructose
4–8  h  25 ◦C  Incubate  in  reagent  1  2  ×  3  days  37 ◦C
Incubate in 40%
formamide
5–30  min  Incubate  in  40%  (wt/vol)
fructose
Incubate  in  PBS  several
times
–  R.T.
Incubate in 80%
formamide
5  min–2  h  Incubate  in  60%  (wt/vol)
fructose
Incubate  reagent  2  3–7  days  37 ◦C
Incubate in 95%
formamide
5–30  min  Incubate  in  80%  (wt/vol)
fructose
12  h
Incubate in 95%
formamide  until  sample
is clear
15  min–2  days  Incubate  in  100%
(wt/vol)  fructose
ClearT2 Incubate  in  80%  (wt/vol)
fructose
24  h
Incubate in 25%
formamide/10%  PEG
10  min–1  h  Incubate  in  87%  (wt/vol)
fructose
37 ◦C
Incubate in 50%
formamide/20%  PEG
5  min–1  h
Incubate  in 50%
formamide/20%  PEG
until  sample  is  clear
15  min–16  h
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Table 1 (Continued)
Clearing  method  (Clarity-based)  Clarity  active  Clarity  passive  PACT/PARS
Tissues  types  tested  Mouse  brain,  human
brain  (post  mortem)
(Chung  et  al.,  2013;
Tomer  et al., 2014);
mouse  brain,  pancreas,
kidney,  lung,  intestine
and  liver  (Lee  et al.,
2014);  spinal  cord
(Zhang  et al., 2014)
Mouse  brain  (Chung
et  al.,  2013;  Tomer  et  al.,
2014)
Mouse  brain,  kidney,
lung,  heart,  intestine  and
tumor  (Yang  et al.,  2014)
Number of  steps/duration  of  procedure  8 steps/8–22  days  5 + x steps/4–6  weeks  up
to months
18  steps/32  days
(Immuno) histochemical  staining  tested  Alexa  Fluor  594  Alexa  Fluor  594  Tyrosine  hydrolase
Tyrosine hydrolase  Tyrosine  hydrolase  Glial  ﬁbrillary  acidic
protein  (GFAP)
Parvalbumin Parvalbumin  Ionized  calcium-binding
adaptor  molecule  1
Glial ﬁbrillary  acidic
protein
Glial  ﬁbrillary  acidic
protein
Integrin  4,  5
Synapsin-1 Synapsin-1  -Tubulin
Postsynaptic density
protein  95
Postsynaptic  density
protein  95
NeuroTrace  530/615  Red
ﬂuorescent  Nissl  dye
Myelin basic  protein  Myelin  basic  protein
Somatostatin Somatostatin
Choline
acetyltransferase
Choline
acetyltransferase
GFP GFP
Microtubule-associated
protein 2
Microtubule-associated
protein  2
Neuroﬁlament Neuroﬁlament
Taul
-Smooth muscle  actin
Alexa  Fluor  488
DAPI  (0.1  f/mL)
NECAB1
NECAB2
CGRP
NF200
Calbindin  D-28K
Calretinin
Secretagogin
GLUT1
GLUT2
Synaptophysin
GFP
PKC-
Cre
Protocol Fix in PFA  Fix in  PFA Fix  in PFA  by perfusion
Embed tissue  in AA  and
BA
2–3  days 4 ◦C Embed  tissue  in AA  and
BA
2–3  days 4 ◦C Perfusion  with  PBS 2  h R.T.
Gas with  nitrogen  Gas  with  nitrogen  Perfusion  with  4%
acrylamide  monomers
(A4P0)  in PBS
Overnight
Polymerize hydrogel  3  h  37 ◦C  Polymerize  hydrogel  3  h 37 ◦C
Remove samples  from
hydrogel
Remove  samples  from
hydrogel
Perfusion  with  PBS
Incubate in clearing
solution
3 ×  1 day  37 ◦C  Incubate  in clearing
solution until  the  sample
is clear
Change  clearing  solution
every  few  days
37 ◦C Gas  with  nitrogen  gas
Incubate in the  ETC
chamber  until  the
sample  is  clear
2–16  days  37–50 ◦C  Polymerization  by
adding  0.25%  VA-044
initiator  in  PBS
37–42 ◦C
Perfusion  with  8% SDS
buffer  in  PBS
2  weeks
Perfusion  with  PBS 8×  2 days
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RI as BABB and DBE cleared tissues well. DBE is hydrophobic like BABB, so tissues have to be dehydrated before clearing but
because dehydration with a series of ethanol reduces ﬂuorescence, ethanol was  replaced by tetrahydrofuran (THF), which
had been introduced as clearing agent by Nultsch in 1954. Mouse brains dehydrated in THF and cleared in BABB appeared
to be completely transparent. Moreover, THF reduces background ﬂuorescence and thus enhances the speciﬁc ﬂuorescence
signal. However, tissue shrinkage was observed when using this protocol.
On the basis of the investigations of Becker et al. (2012), Ertürk et al. (2012a) developed a novel clearing method in 2012,
called 3DISCO. Clearing was performed on unsectioned brain, spinal cord, mammary glands and lung of mice and it appeared
that THF in combination with BABB cleared tissues while ﬂuorescence signals where preserved (Ertürk et al., 2012b). This
ﬁnding was a breakthrough in THF-based clearing and appeared to be particularly useful for lipid-rich tissues. The ﬁrst step
of the method is dehydration with THF, then tissues are transferred to a dichloromethane (DCM) solution, before clearing is
performed in DBE. Tissues became transparent within a few hours, but incubation time in each step depended on the size of
the tissue. However, dehydration has to be performed carefully because when dehydration is too fast, more tissue shrinkage
is observed, due to the fast removal of water.
3DISCO is compatible with various labeling methods, but tissues cannot be stored in DBE for a longer time, because DBE
is aggressive. 3DISCO is now used to clear different types of tissues (Ertürk et al., 2014). Tissue shrinkage is still a problem,
but labeled structures remain intact.
1.6. ClearT
Most tissue clearing methods are reported to cause quenching of ﬂuorescence signals and shrinkage of tissues. Kuwajima
et al. (2013) introduced an alternative clearing method to solve these problems based on the use of formamide, which is
a buffer that is applied in situ hybridisation (Hejatko et al., 2006). The formamide-based clearing method was tested on
whole mouse embryos, heads and brains and was  named ClearT. Tissues became transparent after incubation in a series
of increasing formamide concentrations in buffer, starting with 20% formamide and ending with 95%. The results were
comparable to those of other clearing methods. The tissue became as transparent as with Scale, but the procedure was less
time consuming. ClearT also quenched ﬂuorescence but when Kuwajima et al. (2013) added polyethylene glycol (PEG) to
the clearing solution to stabilize proteins, it resulted in a novel clearing solution, ClearT2, containing 50% formamide and
20% PEG in buffer. This solution preserves ﬂuorescence signals, but the tissue becomes less transparent than when using
ClearT. ClearT also induces tissue volume changes, but they are smaller than when using Scale or BABB.
1.7. SeeDB
Scale appeared to be not the optimal aqueous clearing method, because of fragility of samples, and another clearing
method was introduced by Ke et al. (2013). The method is called SeeDB (for “see deep brain”) and was  developed as aqueous
solution, which clears tissues while ﬂuorescent proteins are preserved and not quenched as has been reported to occur
when using organic solvents as clearing solvents. Ohtsuki et al. (2012) and Tsai et al. (2009) had described a clearing solution
containing high concentrations of sucrose. Ke et al. (2013) investigated various sugar solutions to clear mouse embryos and
brains and found a fructose-containing solution to be the ideal solution for clearing purposes. Fructose is highly water soluble
and do not cause shrinkage of tissue. Brain samples were cleared in 3 days without any shrinkage or swelling of tissues. It
was concluded that tissue swelling as occurs with the Scale approach was  circumvented (Susaki et al., 2014). Furthermore,
SeeDB did not cause morphological or chemical changes of tissues. Occasionally, samples turned brownish, but addition of
thiols to the clearing solution prevented that. SeeDB is easy to apply, inexpensive and no special equipment is necessary.
However, only tissue slices or small tissue specimens can be cleared successfully with SeeDB. Imaging is possible only up to
a depth of 1 mm into the tissue (Marx, 2014). Moreover, SeeDB as clearing solution for long-term imaging evaporates. The
cleared samples are transparent, but not permeable for macromolecules or antibodies, thus limiting the study of biomarkers
in the tissues (Poguzhelskaya et al., 2014).
Calve et al. (2015) also used SeeDB to clear different tissues recently, focusing on skeletal muscle. The authors visualized
the morphology of cleared bone and blood vessels in the skull.
1.8. CLARITY
In 2013, Chung et al. presented a completely new method to clear mouse brains, named CLARITY (Chung et al., 2013).
CLARITY is based on the concept that lipids have to be removed to clear tissue. However, when lipid bilayers of cell membranes
are removed to clear the tissue and to improve diffusion into the tissue, the scaffold of the cell membranes have to be
replaced by another framework to stabilize the tissue. For that purpose, tissue was incubated in a solution of acrylamide
and bisacrylamide monomers that formed polyacrylamide in the tissue after polymerization (Van Noorden and Tas, 1980;
Van Noorden et al., 1984). Then, lipids were removed, using electrophoretic tissue clearing (ETC) instead of clearing using
organic solvents because ETC preserved ﬂuorescence. The chamber in which the ETC takes place functions as an electric
ﬁeld, in which the clearing solution circulates. The clearing solution contains boric acid, sodium dodecyl sulfate, sodium
hydroxide and distilled water. The ETC chamber is not essential to remove lipids, but when ETC is not used, it takes a long
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ime to clear tissues and this approach is called passive CLARITY whereas CLARITY with ETC is called active CLARITY. Active
LARITY also takes quite some time to clear tissues completely (Table 1).
CLARITY has been shown to be successful to clear mouse brain and other organs like pancreas, lung or liver (Lee et al.,
014). The time needed for clearing an adult mouse brain is approximately 8 days. In comparison with other clearing methods,
LARITY causes 8% protein loss from tissues during clearing, whereas the protein loss during Scale clearing, for example,
as 41%.
Like all other methods, active CLARITY has disadvantages. For the clearing procedure, speciﬁc and expensive equipment is
eeded and clearing is slow (Kim et al., 2013). The advantage is that CLARITY allows immunostaining afterwards (Tomer et al.,
014). The hydrogel is nanoporous and antibodies can penetrate into the cleared tissues (Poguzhelskaya et al., 2014). Because
learing in the ETC chamber is technically difﬁcult and time consuming, Poguzhelskaya et al. (2014) followed another route
ith the technique named CLARITY2, also to clear mouse brain. After polymerization and ﬁxation of the hydrogel, tissue
amples were sectioned into thick slices to speed up the clearing procedure. This modiﬁed CLARITY2 method can be used
hen thick tissue slices give sufﬁcient information which depends on the purpose of the study.
.9. CUBIC
Susaki et al. (2014) developed another method to clear mouse brain named CUBIC (clear, unobstructed brain imaging
ocktail) that is in fact a modiﬁcation of Scale and consists of the subsequent use of two reagents. The ﬁrst reagent consists
f N,N,N′,N′-tetrakis(2-hydroxypropyl)ethylenediamine, urea and Triton X-100. Triton X-100 is used to improve diffusion
nto the tissue (Tsai et al., 2009). The second reagent consisting of sucrose, urea, 2,2′,2′-nitrilotriethanol and Triton X-100 is
eeded, because the ﬁrst reagent does not remove all lipids in the tissue specimen. Initially, the concentration of sucrose is
0%, than the tissue is incubated in sucrose solutions with increasingly higher concentrations of sucrose, up to 50%. The ﬁrst
eagent induces some tissue swelling, but the second reagent enables the tissue to return to its normal size. In between the
 incubations in the clearing reagents, immunostaining can be performed. Fluorescence imaging was possible up to a depth
f >750 m,  mainly because permeability of tissues increased after lipid removal.
CUBIC is a simple clearing method and special equipment is not required. It contains only nontoxic water-soluble
hemicals, so it is easy to handle. Clearing lasts approximately 2 weeks. The method has only been tested so far on brain
issue.
.10. PACT/PARS
Another approach to clear tissues was presented by Yang et al. (2014). Mouse brain, kidney, heart and lung have been
leared, as well as human tissue biopsies of basal cell carcinoma. PACT (passive CLARITY technique) and PARS (perfusion-
ssisted agent release in situ) are both improvements of CLARITY passive clearing methods that take a long time. Yang
t al. (2014) tried to ﬁnd a way to speed up passive clearing and investigated whether decreased cross link density of the
ydrogel that embeds the tissue would facilitate lipid extraction. Various concentrations of formaldehyde and acrylamide
ere used whereas bisacrylamide was omitted. The best results were achieved with 4% acrylamide in buffer which preserved
he morphology well. Moreover, step was included to remove oxygen by gassing with nitrogen to speed up polymerization.
nstead of the ETC chamber (Chung et al., 2013), 8% sodium dodecyl sulfate was  used to extract lipids. This clearing method
as called PACT.
PARS is another passive clearing method. The vascular network is used to infuse hydrogel monomers before polymer-
zation and the clearing solution after polymerization. It appeared that tissues were cleared faster and tissue swelling was
educed when using PARS.
.11. iDISCO
Renier et al. (2014) used mouse brain, embryo, muscle, kidney and spinal cord to develop an improvement of the 3DISCO
learing method that is efﬁcient, rapid, does not require special equipment and can be combined with immunolabeling. The
ethod was a combination of whole-mount immunolabeling using Alexa Fluor dyes and 3DISCO, which was named iDISCO
ecause of a better removal of lipids. Rounds of dehydration and rehydration were included and tissues were bleached as
palteholz already did in 1914 (Spalteholz, 1914) using hydrogen peroxide and methanol. Bleaching was  introduced again to
educe auto-ﬂuorescence of tissues and in combination with methanol it improved immunolabeling. One more pretreatment
tep was added to the protocol, using DMSO and Triton X-100 to improve penetration of the tissue.
iDISCO is a simple method that results in transparency of various organs, but its disadvantage is that it quenches the
uorescence signal..12. ACT-PRESTO
ACT-PRESTO is the most recently developed clearing method by Lee et al. (2016). It is an abbreviation for: active clearing
echnique—pressure related efﬁcient and stable transfer of macromolecules into organs.
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It was developed for clearing large specimens in an acceptable period of time, which is the great advantage of this new
method. While clearing with other techniques takes at least a week, clearing with ACT-PREST can be performed within a
day. Furthermore, it is compatible with most immunolabeling techniques and after expanding, the tissue always returns to
its original size.
First, the tissue is ﬁxed in a similar way as in the CLARITY protocol (Chung et al., 2013). The main difference is the higher
porosity of the resulting hydrogel through acrylamide infusion without bis-acrylamide, which enables a better extraction
of lipids. Also the ETC chamber for clearing is modiﬁed with a platinum plate and a cooling system. After clearing, the tissue
is immunolabeled and washed in PBS before imaging.
Lee et al. (2016) not only cleared various organs of mice, like lung, kidney, thymus, liver and brain, but they also cleared
whole bodies of mice, zebraﬁsh and rat embryos successfully.
2. Discussion
The development of confocal microscopy opened the avenue to image cells in 3D with high spatial resolution. Recon-
structions of cells in 3D on the basis of stacks of optical sections produced a wealth of information how cells function.
Furthermore, ﬂuorescent marker molecules and particularly ﬂuorescent proteins in combination with confocal microscopy
promoted our understanding of cell functioning tremendously. Especially, live cell cytochemistry and imaging opened the
eyes of cell biologists for the enormous dynamics of cell activity. Cell biological text books had to be rewritten.
The next step is imaging of cells in their natural habitat in tissues. Histologists and histochemists realized that 3D imaging
of living tissues will become, no doubt, a similar revolution in our understanding of how tissues function in health and disease
as live cell imaging was for the cell biological discipline. Tissues are still studied in 2D in tissue sections and this approach
forms the basis of histology text books. Once we  are able to perform histology of live tissues in 3D, we will have to rewrite
the histology textbooks as well. However, imaging of live tissues in 3D is still a bridge too far. The main reason for that is
the opaqueness of tissues that limits imaging to a depth of 500–1000 m at best (Weigelin et al., 2016) despite the rapid
developments in imaging such as 2-photon confocal microscopy.
At present, two major directions are taken to solve these issues. First, imaging of live tissues is performed in the superﬁcial
cell layers of a tissue in time to visualize the dynamics in these cell layers (Weigelin et al., 2016) or transparent organisms
are used such as zebraﬁsh embryos (Vittori et al., 2015). Second, opaque tissues are being cleared for imaging of a tissue
over its entire depth. The present review discusses the clearing methods that are presently available (Table 1). Spalteholz
introduced clearing of tissues already a century ago (Spalteholz, 1911), but only in the last decade clearing of tissues was
the topic of intense research. The availability and continuous improvements of imaging techniques such as 1-photon and
2-photon microscopy and light-sheet microscopy were a strong stimulus of this research in clearing techniques. The clearing
methods that are available now can be roughly divided into 3 groups: First, the CLARITY-based clearing methods such as
active CLARITY, passive CLARITY, PACT and PARS, second, the aqueous clearing methods such as SeeDB, CUBIC, ClearT, and
Scale, and third, the non-aqueous clearing methods such as BABB, 3DISCO and iDISCO.
The principle of CLARITY-based methods is the formation of an artiﬁcial skeleton of polymerized acrylamide (polyacry-
lamide). The polyacrylamide skeleton has been introduced in the eighties of last century for quantitative cytochemistry of
individual cells and in particular for the visualization and quantiﬁcation of the activity of enzymes in cells using enzyme
cytochemistry, also called metabolic mapping (Fig. 2; De Schepper et al., 1985; Van Noorden et al., 1982, 1984). The arti-
ﬁcial polyacrylamide skeleton kept enzymes in their subcellular location and the colored product that was generated by
the enzyme under study was precisely localized at the location of the activity of the enzyme (Van Noorden, 2010). This
methodology was applied by Chung et al. (2013) for 3D histochemistry and imaging of entire mouse brains. After infusion of
acrylamide and bisacrylamide monomers into the brain tissue and subsequent polymerization to build the artiﬁcial skele-
ton, the brain is cleared from lipids to remove cell membranes which clears the brain tissue excellently. However, other
types of tissues and in particular extracellular matrix-rich tissues such as connective tissue or stroma (e.g. the dermis in
skin or gingiva) cannot be properly cleared by CLARITY-based methods. Brain virtually lacks extracellular matrix and thus
opaqueness of the tissue is mainly caused by cell membranes, whereas the extracellular matrix also causes opaqueness of
tissue.
The aqueous clearing methods have thus far only been used for tissues without much extracellular matrix such as brain,
heart, pancreas and kidney. Furthermore, embryos have been cleared successfully with these aqueous clearing methods but
again, mainly for clearing the brain. The images of embryos in these articles all show areas outside the brain where clearing
was not successful. Moreover, Renier et al. (2014) reported that resulting transparency is not sufﬁcient for high resolution
imaging. Furthermore, Susaki et al. (2014) acquired highly-transparent tissues using 3DISCO and CLARITY, whereas tissues
cleared with Scale and SeeDB did not become transparent. It was  proposed that CUBIC is a good alternative to fully clear
tissue with an aqueous solution, which should be tested on mouse skin or gingiva in the future. Aqueous solutions change the
composition of tissues, which results in a higher permeability. This fact is useful for immunostaining, because penetration
of antibodies or dyes is faster (Susaki et al., 2014). According to Genina et al. (2010), Hama et al. (2011) and Ke et al. (2013),
another advantage of aqueous clearing solutions is preservation of ﬂuorescence in tissues which was reported not to be
the case in hydrophobic clearing solutions such as BABB and DBE. However, ﬂuorescence signals remained intact in our
experiments on skin and gingiva clearing with BABB or iDISCO (unpublished data).
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Fig. 2. (a) Isolated ﬁbroblasts incorporated in polyacrylamide gel and then stained for G6PD activity. (b) Larger magniﬁcation of ﬁbroblasts incorporated in
polyacrylamide and then stained for G6PD activity. c) Isolated hepatocytes incorporated in polyacrylamide and then stained for G6PD activity. (d) Oocyte
with polar body incorporated in polyacrylamide gel and then stained for G6PD activity; (e) Oocyte without polar body in polyacrylamide gel after staining
for  G6PD activity. (f) Oocyte incorporated in polyacrylamide gel that was  dissected in two  parts and (1) incubated for G6PD activity in the absence of
substrate (control) and (2) in the presence of substrate (test). Brownish-reddish colour represents G6PD activity and in (f) the speciﬁcity of the staining
reaction for G6PD activity is shown because in the presence of substrate colour is generated but not in the absence of substrate.
Fig. 3. Clearing of mouse skin and subsequent imaging on lettering paper (type font: Calibri (bold), type size: 8). (a1) Mouse skin cleared with active
CLARITY after 4 days of electrophoretic tissue clearing. (a2) Mouse skin cleared with passive CLARITY after 11 weeks of incubation in the clearing solution.
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lb1)  Mouse skin cleared with iDISCO. (b2) Mouse skin cleared with iDISCO and immersed in dibenzylether (DBE) for 15 min. (c1) Mouse skin cleared with
ABB. (c2) Mouse skin cleared and immersed in BABB for 30 min.
CUBIC should be preferred to SeeDB and Scale, because Hama et al. (2011), Ke et al. (2013), Parra et al. (2012) and
oguzhelskaya et al. (2014) describe that samples cleared with Scale become soft and fragile while samples cleared with
eeDB suffer from limited permeability, and large tissue samples cannot be cleared properly. Alternatively, clearing tissue
ith SeeDB can be performed at higher temperatures to increase permeability. However, clearing at higher temperatures
uenches ﬂuorescence and thus is the advantage of preserved ﬂuorescence lost in samples cleared with aqueous solutions.The non-aqueous clearing methods such as BABB, iDISCO and probably 3Disco have been excellent tools in our hands to
ompletely clear skin and gingiva (Figs. 3 and 4). Moreover, the clearing itself is ready in a few hours and the entire procedure
asts only 4 h.
20 A. Azaripour et al. / Progress in Histochemistry and Cytochemistry 51 (2016) 9–23Fig. 4. Clearing of gingiva and subsequent imaging on lettering paper (type font: Calibri (bold), type size: 8). (a) Gingiva embedded in agarose after clearing
with  BABB. (b) Gingiva after clearing with active CLARITY. (c) Gingiva embedded in agarose after clearing with iDISCO.
Mouse skin and human gingiva did not become optically transparent following active and passive CLARITY clearing,
despite the fact that Chung et al. (2013) claim that their method can clear every tissue. Apparently, CLARITY is not suitable
for clearing of tissues that contain high amounts of extracellular matrix such as skin or gingiva (Fig. 3a). Furthermore, active
CLARITY is a complex method and expensive equipment is needed. These disadvantages of active CLARITY were also reported
by Ke et al. (2013), Susaki et al. (2014) and Yang et al. (2014). Passive CLARITY clearing, that does not involve the expensive
equipment, may  need months to clear a tissue, which does not make it user-friendly.
BABB and DBE-based iDISCO are favorable solutions for connective tissue, because these solutions are easy to use, no
special equipment is needed and the clearing procedure is fast. After clearing skin or gingiva according to BABB or iDISCO
protocols, all samples became completely transparent (Figs. 3b and 4). Ertürk et al. (2012a) described problems when clearing
brain tissue with DBE, but in our study clearing skin and gingiva with iDISCO was  ﬁne. The effects of clearing procedures
differ for the various tissues (Becker et al., 2012), and skin and gingiva are cleared more effectively with DBE than brain with
DBE.
No other clearing methods were tested by us because BABB and iDISCO both cleared skin and gingiva completely in a fast
and user-friendly fashion. Clearing with aqueous methods was not tested yet.
A further advantage of BABB and iDISCO is the expedition of the clearing procedures. For example, samples need around
two weeks to become transparent when using CUBIC (Susaki et al., 2014). Time for ﬁxing and staining tissue has to be added
on top of that. When compared to other aqueous clearing techniques, CUBIC can be considered to be a fast procedure, because
other aqueous methods like Scale need up to six month for proper clearing (Parra et al., 2012). Ertürk et al. (2012a) reported
that tissue samples are cleared with 3DISCO within a few hours. Clearing with BABB or iDISCO was even faster. We needed
2.5 days to clear a skin or gingiva sample completely with both methods. Becker et al. (2012) reported that clearing with
iDISCO was even faster than with BABB. Becker et al. (2008) needed two  days to clear mouse embryos in BABB. However,
clearing of skin or gingiva samples lasted only 1–4 h and the entire procedure from collecting tissue samples up to complete
transparency lasted 4 days.
Most clearing methods have particular advantages. For example, CLARITY and CUBIC are good for imaging endogenous
ﬂuorescence (Renier et al., 2014), Scale and SeeDB are speciﬁcally useful for embryonic tissue (Ertürk et al., 2014). Ertürk
et al. (2012a) describe 3DISCO to be useful for clearing of all types of tissues. We  like to add here that BABB and iDISCO are
useful for extracellular matrix-rich tissues such as skin and gingiva.
When comparing transparency of samples cleared with BABB and iDISCO, no differences could be observed in the present
study (Figs. 3 and 4). This contradicts the results of Ertürk et al. (2012a) and Becker et al. (2012), who found samples to be
cleared with DBE to be more transparent than those cleared with BABB.
Protocols describing clearing with BABB vary, such as those of Becker et al. (2008, 2013, 2012), Jährling et al. (2009) and
Parra et al. (2012). The main difference between the protocols is the ﬁnal dehydration step, which can be performed with
the use of either ethanol or THF. The present study is based on the protocol of Becker et al. (2012), using THF. Ertürk et al.
(2012a,b) and Becker et al. (2012) state that THF better preserves ﬂuorescence signals. In our experiments ﬂuorescence
signals were preserved as well. We  also used autoﬂuorescence signals of gingiva for imaging. Therefore, it can be concluded
that BABB and iDISCO containing DBE are methods that preserve ﬂuorescence.
Whether ﬂuorescence is quenched or not in hydrophobic clearing solutions such as BABB and DBE appears to be not
investigated very well. When studying the relevant literature (Becker et al., 2012; Ertürk et al., 2012a,b; Genina et al., 2010;
Hama et al., 2011; Ke et al., 2013; Kuwajima et al., 2013; Yushchenko and Schultz, 2013), it appears that a proper analysis of
the effects of a clearing solution on ﬂuorescence signals has not been performed. Moreover, the literature on effects of BABB
or DBE on ﬂuorescence signals is not equivocal (Becker et al., 2012; Ertürk et al., 2012a,b; Yushchenko and Schultz, 2013)
and experts in the ﬂuorescence ﬁeld that we have consulted are convinced that ﬂuorescence is not dependent on an aqueous
environment and assume that it depends on the ﬂuorescent molecule whether it ﬂuoresces in an hydrophobic environment
as we have observed ourselves with Alexa dyes, phycoerythrin and autoﬂuorescence (unpublished data). It may  be possible
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hat ﬂuorescent proteins are quenched in hydrophobic clearing solutions because the 3D molecular structure of proteins is
ost, but again, this has to be investigated properly.
To reduce background signals while imaging, Renier et al. (2014) recommended to treat samples with heparin before
he ﬁnal dehydration. However, this treatment appeared to have quenching effects. As methanol has also quenching effects,
enier et al. (2014) suggested a modiﬁed clearing method without using methanol. The additional step of heparin treatment
akes the clearing process more time consuming. In the present study, loss of ﬂuorescence signals was  not observed and
hus, amendments of the iDISCO protocol as suggested by Renier et al. (2014) were not tested.
Although it has been reported that BABB and DBE quench ﬂuorescence signals in tissues (Ertürk et al., 2012a), it was
lso found that even after 3 months of storage, ﬂuorescence signals were still be detectable in tissues stored in BABB. Alexa
luor® ﬂuorescence was found to be stable for a few months in BABB (Renier et al., 2014).
Besides, differences in the effect of dehydration with ethanol or methanol have also been described. Parra et al. (2012)
roposed ethanol to be used for better preservation of ﬂuorescence signals. Becker et al. (2008) and Jährling et al. (2009)
orroborate these ﬁndings and use ethanol for dehydration. In our study, methanol was  used for clearing of gingiva samples
nd we did not ﬁnd any loss of ﬂuorescence signals, irrespective whether the iDISCO or BABB protocol was followed.
Clearing with organic solvents has the disadvantage of toxicity and aggressiveness. Organic clearing solutions have to
e handled carefully. Parra et al. (2012) found out that BABB can dissolve glue. Therefore, application of BABB and DBE in
etri dishes and coverslips was tested ﬁrst before imaging gingiva. Our ﬁndings were in agreement with those of Parra et al.
2012), as BABB and DBE indeed dissolved glue. As an alternative, dental cement was  tried for imaging (Ertürk et al., 2012a).
he ring formed on a coverslip did not dissolve, but did not stick properly to the glass either. Therefore, this approach could
ot be used. However, a metal ring around the tissue sample solved the problem for confocal microscopy whereas light-sheet
icroscopes have a chamber especially designed for solutions like DBE and BABB.
Imaging is only successful when the appropriate imaging solution is used. When the RI of the tissue is different from that
f the imaging solution, light is scattered which blurs the image and limits the penetration of the laser light into the tissue
ample. Glycerol cannot be used as imaging solution because according to Richardson and Lichtman (2015) the RI of the
maging solution and the tissue and glass coverslips and immersion oil differs too much. Moreover, glycerol is viscous, and
ubbles are introduced easily during handling, which makes imaging impossible. Finally, glycerol is hydrophilic, while BABB
nd DBE are hydrophobic, and glycerol does not penetrate the tissue that has been cleared with DBE (Ertürk et al., 2014).
he best results were obtained when imaging the tissue in its clearing solution. Tissues that were cleared in BABB can also
e imaged in DBE as imaging solution, because the RIs of both solutions are nearly identical. For tissue cleared in aqueous
olutions, other imaging solutions than glycerol have been proposed. FocusClear has been used by Chung et al. (2013) to
mage tissue that has been cleared with CLARITY. It contains DMSO, diatrizoate acid and other reagents (Genina et al., 2010),
ut the exact composition is proprietary. As a result, FocusClear is expensive and cannot be optimized for the various tissues
ther than brain (Hama et al., 2011). Although it has been described for imaging tissue using a confocal microscope (Chiang
t al., 2001; Chung et al., 2013; Fu et al., 2009), it was not necessary to test imaging with FocusClear in the present study.
arx (2014) also reported that FocusClear is not necessary.
To summarize our review of methods particularly for clearing human extracellular-rich tissue, it can be stated, that the
est results are obtained when these tissues are cleared with BABB or iDISCO.
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